BIOMAT Database Logo BIOMAT Database Logo

Presence of serotonin1A (5-HT1A) receptor mRNA without binding of [3H]-8-OH-DPAT in peripheral blood mononuclear cells. 1995

D Marazziti, and L Palego, and B Dal Canto, and A Rotondo, and M Pasqualetti, and G Gino, and A Lucacchini, and H Ladinsky, and I Nardi, and G B Cassano
Institute of Psychiatry, Pisa.

The authors investigated the presence of serotonin receptor type 1A (5-HT1A) as labeled by the specific ligand 3H-8 hydroxy-2-(di-N-propylamino)tetralin (3H-8-OH-DPAT) in saturation experiments, and the expression of the mRNA encoding them, in human peripheral blood mononuclear cells (PBMC). In situ hybridization experiments were performed as well. The results, showing that the binding of [3H]-8-OH-DPAT to lymphocyte membranes increased linearly up to 100 nM without reaching saturation, may indicate that the 3H-8-OH-DPAT was not specifically labeling the 5-HT1A receptor. By contrast, the expression studies revealed 5-HT1A mRNA in PBMC. These findings suggest that, despite the presence of mRNA, 5-HT1A receptors are not expressed in PBMC, at least in healthy controls.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012260 Ribonucleases Enzymes that catalyze the hydrolysis of ester bonds within RNA. EC 3.1.-. Nucleases, RNA,RNase,Acid Ribonuclease,Alkaline Ribonuclease,Ribonuclease,RNA Nucleases,Ribonuclease, Acid,Ribonuclease, Alkaline
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014316 Tritium The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES. Hydrogen-3,Hydrogen 3

Related Publications

D Marazziti, and L Palego, and B Dal Canto, and A Rotondo, and M Pasqualetti, and G Gino, and A Lucacchini, and H Ladinsky, and I Nardi, and G B Cassano
The 5-HT1A receptor probe [3H]8-OH-DPAT labels the 5-HT transporter in human platelets.
January 1988, Life sciences,
D Marazziti, and L Palego, and B Dal Canto, and A Rotondo, and M Pasqualetti, and G Gino, and A Lucacchini, and H Ladinsky, and I Nardi, and G B Cassano
Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
April 1998, European journal of pharmacology,
D Marazziti, and L Palego, and B Dal Canto, and A Rotondo, and M Pasqualetti, and G Gino, and A Lucacchini, and H Ladinsky, and I Nardi, and G B Cassano
Apparent regional differences in 5-HT1A binding may reflect [3H]8-OH-DPAT labeling of serotonin uptake sites.
July 1993, Brain research,
D Marazziti, and L Palego, and B Dal Canto, and A Rotondo, and M Pasqualetti, and G Gino, and A Lucacchini, and H Ladinsky, and I Nardi, and G B Cassano
Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
June 1986, Biochemical pharmacology,
D Marazziti, and L Palego, and B Dal Canto, and A Rotondo, and M Pasqualetti, and G Gino, and A Lucacchini, and H Ladinsky, and I Nardi, and G B Cassano
Pharmacological characterisation of the 5-HT1A serotonin receptor using the agonist [3H]8-OH-DPAT, and the antagonist [3H]spiperone.
May 1992, Biochemical Society transactions,
D Marazziti, and L Palego, and B Dal Canto, and A Rotondo, and M Pasqualetti, and G Gino, and A Lucacchini, and H Ladinsky, and I Nardi, and G B Cassano
Effects of autoshaping procedures on 3H-8-OH-DPAT-labeled 5-HT1a binding and 125I-LSD-labeled 5-HT2a binding in rat brain.
June 2003, Brain research,
D Marazziti, and L Palego, and B Dal Canto, and A Rotondo, and M Pasqualetti, and G Gino, and A Lucacchini, and H Ladinsky, and I Nardi, and G B Cassano
[3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
December 1988, The Journal of pharmacy and pharmacology,
D Marazziti, and L Palego, and B Dal Canto, and A Rotondo, and M Pasqualetti, and G Gino, and A Lucacchini, and H Ladinsky, and I Nardi, and G B Cassano
Actions of the prototypical 5-HT1A receptor agonist 8-OH-DPAT at human alpha2-adrenoceptors: (+)8-OH-DPAT, but not (-)8-OH-DPAT is an alpha2B subtype preferential agonist.
August 2010, European journal of pharmacology,
D Marazziti, and L Palego, and B Dal Canto, and A Rotondo, and M Pasqualetti, and G Gino, and A Lucacchini, and H Ladinsky, and I Nardi, and G B Cassano
Prenatal stress influences 8-OH-DPAT modulated startle responding and [3H]-8-OH-DPAT binding in rats.
July 2005, Pharmacology, biochemistry, and behavior,
D Marazziti, and L Palego, and B Dal Canto, and A Rotondo, and M Pasqualetti, and G Gino, and A Lucacchini, and H Ladinsky, and I Nardi, and G B Cassano
Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT.
June 2002, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!